Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study

Bibliographic Details
Main Authors: Dong, Qian, Yang, Xiang-hong, Zhang, Yao, Jing, Wei, Zheng, Li-qiang, Liu, Yun-peng, Qu, Xiu-juan
Format: Online
Language:English
Published: BioMed Central 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064278/
id pubmed-4064278
recordtype oai_dc
spelling pubmed-40642782014-06-21 Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study Dong, Qian Yang, Xiang-hong Zhang, Yao Jing, Wei Zheng, Li-qiang Liu, Yun-peng Qu, Xiu-juan Research BioMed Central 2014-06-02 /pmc/articles/PMC4064278/ /pubmed/24890327 http://dx.doi.org/10.1186/1477-7819-12-171 Text en Copyright © 2014 Dong et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Dong, Qian
Yang, Xiang-hong
Zhang, Yao
Jing, Wei
Zheng, Li-qiang
Liu, Yun-peng
Qu, Xiu-juan
spellingShingle Dong, Qian
Yang, Xiang-hong
Zhang, Yao
Jing, Wei
Zheng, Li-qiang
Liu, Yun-peng
Qu, Xiu-juan
Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study
author_facet Dong, Qian
Yang, Xiang-hong
Zhang, Yao
Jing, Wei
Zheng, Li-qiang
Liu, Yun-peng
Qu, Xiu-juan
author_sort Dong, Qian
title Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study
title_short Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study
title_full Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study
title_fullStr Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study
title_full_unstemmed Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study
title_sort elevated serum ca19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study
description
publisher BioMed Central
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064278/
_version_ 1612103981080772608